Novavax Shares Drop as FDA Requests New Trial for COVID-19 Vaccine Approval

Published 8 days agoNVAX

Novavax Shares Drop as FDA Requests New Trial for COVID-19 Vaccine Approval

Novavax's stock fell by 4.8% to $6.73 after the FDA requested an additional clinical trial to evaluate the effectiveness of its COVID-19 vaccine. The Wall Street Journal reported that the agency's request has delayed the vaccine's path to full approval in the U.S.

According to Reuters, the FDA has urged Novavax to provide more conclusive evidence regarding its vaccine's efficacy before it can receive final approval. The report also suggests that the approval process is being influenced by recent political appointees, potentially affecting the speed of the decision-making process.

Novavax has yet to issue an official response to the FDA's request. The company is currently navigating regulatory challenges amid discussions about vaccine approval expectations. However, as of the report, there was no comment from Novavax on the specific details of the FDA's demands or the implications for their vaccine rollout plans.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Bela Bajaria Discusses Overcoming Career Setbacks

Bela Bajaria Discusses Overcoming Career Setbacks

16 minutes agoNFLX

Bela Bajaria, Netflix's Chief Content Officer, previously opened up about a major career setback during an interview in 2022. Although recent events at the 2025 Changemakers Summit were not publicly addressed, Bajaria's past experiences provide insight into her resilience and leadership in the entertainment industry. In her earlier role as President of Universal Television, Bajaria faced a significant professional hurdle. Despite her success in transforming the studio and rolling out popular shows, she was dismissed following tensions between the network and studio. She candidly shared the personal challenge of explaining this situation to her children and the necessity of not tying one's identity solely to their career. Bajaria stressed the importance of mourning setbacks and focusing on rebuilding. Bajaria's journey from this career low point to her current position highlights her capacity for growth and learning. She sees these experiences as crucial to her development, ultimately leading her to her significant role at Netflix. Her story serves as an example of turning adversity into opportunity, though further details about any recent public appearances would need to be verified through official communications or reputable sources like those from Netflix or Reuters.

Upcoming Earnings Reports: AMD, Pfizer, Disney, and More

Upcoming Earnings Reports: AMD, Pfizer, Disney, and More

The week starting Monday, May 5, 2025, will be an eventful one for earnings reports, with several major companies set to reveal their financial results. AMD, a key player in the tech sector, is among the companies to watch as it prepares to release its earnings on Tuesday, May 6. Super Micro Computer will also share its quarterly performance on the same day. Tuesday itself will see Pfizer, the pharmaceutical giant, report its earnings, bringing potential insights into the healthcare sector's ongoing performance. As the week unfolds, investors will get additional insights when The Walt Disney Company and Coinbase Global reveal their results on Wednesday, May 7. These reports should provide a glimpse into the entertainment and cryptocurrency markets. Later in the week on Thursday, May 8, Plug Power and SoundHound AI are scheduled to disclose their financials, while Friday rounds out the week with Applied Digital Corporation and Future FinTech Group set to announce their earnings. This week's series of earnings calls offer a snapshot of various industries' health and are pivotal for investors aiming to gauge market conditions. Reuters highlighted the importance of staying updated with any changes to the schedule as company announcements may shift.

GameChanger's Growing Role in Dick's Sporting Goods' Future

GameChanger's Growing Role in Dick's Sporting Goods' Future

Dick's Sporting Goods subsidiary, GameChanger, is being recognized as a major long-term growth driver for the company. Known for its mobile app and website offering services like scorekeeping, statistics, video streaming, and recap stories, GameChanger caters to local sports teams and has become a significant digital asset for Dick's since its acquisition in 2016. GameChanger's platform has supported over 24 million games with more than 500,000 active scoring teams, illustrating strong user engagement across various sports and age groups. Operating on a freemium model, it provides basic services for free while generating revenue through subscriptions for premium fan content. Its recent partnership with Major League Baseball, announced in June 2023, further integrates GameChanger's data into MLB Network and MLB.com, providing enhanced visibility and growth potential. The analyst believes that GameChanger's expanding user base, strategic MLB partnership, and its innovative freemium model position it as a pivotal component of Dick's Sporting Goods' growth strategy. By diversifying its digital engagements within the sports community, GameChanger is set to play a key role in boosting Dick's Sporting Goods' overall market reach and profitability.

AT&T Impresses with Strong Dividend and Subscriber Growth

AT&T Impresses with Strong Dividend and Subscriber Growth

AT&T is making headlines as a top choice for dividend-seeking investors, boasting a dividend yield of approximately 5.2%. This stability has caught the attention of Wall Street analysts, who continue to view AT&T as a strong investment. The company is recognized for offering a reliable income stream alongside prospects for growth. In terms of performance, AT&T has made significant strides. In the first quarter of 2024, AT&T successfully added 349,000 net monthly bill-paying wireless subscribers, surpassing the expected number of 286,800. Moreover, AT&T's broadband revenue saw a notable increase of 7.7%, fueled by the expansion of its fiber network. Analysts such as Tigress Financial Partners' Ivan Feinseth and Scotiabank's Maher Yaghi maintain 'Buy' ratings on the stock, with Feinseth targeting a price of $30 and Yaghi boosting his target to $28.5. AT&T's future strategy includes returning over $40 billion to its shareholders through dividends and stock buybacks by 2026, starting with an initial $10 billion repurchase plan. This strategic approach underlines AT&T's commitment to maintaining robust shareholder returns, reinforcing its standing as a top dividend stock with consistent performance. Reuters reported these developments, highlighting the company's reliable track record.